ERBB2 and triple-negative breast carcinoma: Moreover, the inherently aggressive nature of HER2-positive and triple-negative breast cancers may have contributed to a greater likelihood of regional or distant recurrence rather than isolated local recurrence, thereby precluding surgical management in these cases.